GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Luoxin Pharmaceuticals Group Stock Co Ltd (SZSE:002793) » Definitions » Cyclically Adjusted Revenue per Share

Luoxin Pharmaceuticals Group Stock Co (SZSE:002793) Cyclically Adjusted Revenue per Share : ¥3.95 (As of Mar. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Luoxin Pharmaceuticals Group Stock Co Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Luoxin Pharmaceuticals Group Stock Co's adjusted revenue per share for the three months ended in Mar. 2024 was ¥0.564. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ¥3.95 for the trailing ten years ended in Mar. 2024.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2024-06-18), Luoxin Pharmaceuticals Group Stock Co's current stock price is ¥3.96. Luoxin Pharmaceuticals Group Stock Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was ¥3.95. Luoxin Pharmaceuticals Group Stock Co's Cyclically Adjusted PS Ratio of today is 1.00.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Luoxin Pharmaceuticals Group Stock Co was 1.32. The lowest was 0.97. And the median was 1.15.


Luoxin Pharmaceuticals Group Stock Co Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Luoxin Pharmaceuticals Group Stock Co's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Luoxin Pharmaceuticals Group Stock Co Cyclically Adjusted Revenue per Share Chart

Luoxin Pharmaceuticals Group Stock Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 3.99

Luoxin Pharmaceuticals Group Stock Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 3.99 3.95

Competitive Comparison of Luoxin Pharmaceuticals Group Stock Co's Cyclically Adjusted Revenue per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Luoxin Pharmaceuticals Group Stock Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Luoxin Pharmaceuticals Group Stock Co's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Luoxin Pharmaceuticals Group Stock Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Luoxin Pharmaceuticals Group Stock Co's Cyclically Adjusted PS Ratio falls into.



Luoxin Pharmaceuticals Group Stock Co Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Luoxin Pharmaceuticals Group Stock Co's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.564/115.2271*115.2271
=0.564

Current CPI (Mar. 2024) = 115.2271.

Luoxin Pharmaceuticals Group Stock Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201212 0.000 95.237 0.000
201312 0.000 97.624 0.000
201412 0.000 99.000 0.000
201503 0.449 99.900 0.518
201506 0.748 99.500 0.866
201509 0.495 100.500 0.568
201512 0.600 100.600 0.687
201603 0.559 102.200 0.630
201606 0.644 101.400 0.732
201609 0.423 102.400 0.476
201612 0.461 102.600 0.518
201703 0.544 103.200 0.607
201706 0.713 103.100 0.797
201709 0.565 104.100 0.625
201712 0.619 104.500 0.683
201803 0.576 105.300 0.630
201806 0.784 104.900 0.861
201809 0.550 106.600 0.595
201812 5.201 106.500 5.627
201903 1.724 107.700 1.844
201906 1.884 107.700 2.016
201909 1.596 109.800 1.675
201912 1.626 111.200 1.685
202003 0.800 112.300 0.821
202006 0.957 110.400 0.999
202009 1.176 111.700 1.213
202012 1.126 111.500 1.164
202103 1.108 112.662 1.133
202106 1.102 111.769 1.136
202109 1.186 112.215 1.218
202112 0.963 113.108 0.981
202203 1.599 114.335 1.611
202206 0.607 114.558 0.611
202209 0.436 115.339 0.436
202212 -0.139 115.116 -0.139
202303 0.587 115.116 0.588
202306 0.601 114.558 0.605
202309 0.491 115.339 0.491
202312 0.509 114.781 0.511
202403 0.564 115.227 0.564

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Luoxin Pharmaceuticals Group Stock Co  (SZSE:002793) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Luoxin Pharmaceuticals Group Stock Co's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=3.96/3.95
=1.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Luoxin Pharmaceuticals Group Stock Co was 1.32. The lowest was 0.97. And the median was 1.15.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Luoxin Pharmaceuticals Group Stock Co Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Luoxin Pharmaceuticals Group Stock Co's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Luoxin Pharmaceuticals Group Stock Co (SZSE:002793) Business Description

Traded in Other Exchanges
N/A
Address
85 Faraday Road, Floor 1-3, Building 1, Building 2, Pilot Free Trade Zone, Shanghai, CHN, 201203
Luoxin Pharmaceuticals Group Stock Co Ltd is a pharmaceutical enterprise engaged in research and development, production, and trade of new drugs. It manufactures drugs for various diseases including tumor, respiratory, gastrointestinal, endocrine, cardiovascular, nervous system, antimicrobial infection, among others.
Executives
Ye Bang Mi Supervisors
Fang Xiu Bao Directors, executives
Zhu Fu Lin Directors, executives
Chen Li Supervisors
Yao Liang Directors, executives

Luoxin Pharmaceuticals Group Stock Co (SZSE:002793) Headlines

No Headlines